Avalere says FDA has not kept pace with innovation despite rising fees . . .

FDA, Stakeholders Emphasize Importance Of Staffing To PDUFA Success

August 15, 2016 at 7:16 PM
FDA officials, patient representatives and industry stakeholders said the hiring provisions included in the drug user fee commitment letter are critical to the other goals outlined for the sixth iteration of the program, with an industry representative saying FDA’s ability to recruit scientists is crucial to the agency keeping pace with scientific advancement. But as the agency and stakeholders discussed the proposed recommendations for the Prescription Drug User Fee Act at a meeting Monday (Aug. 15), Avalere released an analysis...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.